TMCNet:  Research and Markets: Respiratory Depression - Pipeline Review, H1 2012

[April 02, 2012]

Research and Markets: Respiratory Depression - Pipeline Review, H1 2012

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/83528eb2/respiratory_depres) has announced the addition of Global Markets Direct's new report "Respiratory Depression - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Respiratory Depression - Pipeline Review, H1 2012', provides an overview of the Respiratory Depression therapeutic pipeline. This report provides information on the therapeutic development for Respiratory Depression, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Depression. 'Respiratory Depression - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specificthird party sources, put together by Global Markets Direct's team.

Key Topics Covered:

  • List of Tables
  • List of Figures
  • Introduction
  • Global Markets Direct Report Coverage
  • Respiratory Depression Overview
  • Therapeutics Development
  • An Overview of Pipeline Products for Respiratory Depression
  • Respiratory Depression Therapeutics under Development by Companies
  • Late Stage Products
  • Comparative Analysis
  • Mid Clinical Stage Products
  • Comparative Analysis
  • Pre-Clinical Stage Products
  • Comparative Analysis
  • Respiratory Depression Therapeutics - Products under Development by Companies
  • Companies Involved in Respiratory Depression Therapeutics Development
  • Cortex Pharmaceuticals, Inc.
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Respiratory Depression - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Drug Profiles
  • Respiratory Depression Therapeutics - Drug Profile Updates
  • Respiratory Depression Therapeutics - Discontinued Products
  • Respiratory Depression Therapeutics - Dormant Products
  • Respiratory Depression - Product Development Milestones
  • Featured News & Press Releases
  • Appendix
  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation
  • Contact Us
  • Disclaimer

For more information visit http://www.researchandmarkets.com/research/83528eb2/respiratory_depres

Source (News - Alert): Global Markets Direct


[ Back To Homepage ]


FOLLOW US
Software Telco Congress

Virtualization has taken the IT world by storm but to date the comms market has been mostly unaffected – relying instead on proprietary appliances for numerous functions. A recent industry push to establish network standards virtualization will potentially shake-up the telecommunications market even more than the move to IP communications. As network hardware begins to be released as software, carriers are expected to save money and benefit greatly from new levels of flexibility related to hosting their network in private and virtual private clouds.

Software Telco Congress Benefits:


Who Will Attend:

Tier 1, 2 and 3 Telcos

Most Popular Articles